Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years

Leuk Lymphoma. 2018 Nov;59(11):2700-2705. doi: 10.1080/10428194.2018.1439584. Epub 2018 Mar 12.

Authors

Nicola Polverelli¹, Michele Malagola¹, Alessandro Turra¹, Cristina Skert¹, Simone Perucca^{1

2}, Marco Chiarini³, Federica Cattina¹, Benedetta Rambaldi¹, Valeria Cancelli¹, Enrico Morello¹, Francesca Schieppati¹, Simona Bernardi^{1

2}, Camilla Zanaglio^{1

2}, Alessandra Sottini², Viviana Giustini², Luisa Imberti², Alessandro Montanelli³, Domenico Russo¹

Affiliations

¹ a Unit of Blood Diseases and Stem Cells Transplantation, Department of Clinical and Experimental Sciences , University of Brescia, ASST Spedali Civili of Brescia , Brescia , Italy.
² b Laboratorio CREA (Centro di Ricerca Emato-oncologica AIL) , ASST Spedali Civili of Brescia , Brescia , Italy.
³ c Clinical Chemistry Laboratory, Department of Diagnostics , ASST Spedali Civili of Brescia , Brescia , Italy.

PMID: 29527964
DOI: 10.1080/10428194.2018.1439584

No abstract available

Publication types

Clinical Trial
Comparative Study
Letter

MeSH terms

Adult
Aged
Antilymphocyte Serum / administration & dosage*
Female
Follow-Up Studies
Graft vs Host Disease / prevention & control*
Hematologic Neoplasms / pathology
Hematologic Neoplasms / therapy*
Hematopoietic Stem Cell Transplantation / mortality*
Humans
Immunosuppressive Agents / administration & dosage*
Male
Middle Aged
Prognosis
Retrospective Studies
Survival Rate
Transplantation, Homologous
Unrelated Donors

Substances

Antilymphocyte Serum
Immunosuppressive Agents
thymoglobulin